Certolizumab pegol is an anti-TNF (anti-tumour necrosis factor) drug. It blocks the action of TNF protein and so reduces inflammation in conditions including rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. BioSim? Vedolizumab ELISA kit is a Solid phase enzyme-linked immunosorbent assay (ELISA) based on the sandwich principle. Standards and samples (serum or plasma) are incubated in the microtitre plate coated with the reactant for Certolizumab pegol (Cimzia?). After incubation, the wells are washed. A horse radish peroxidase (HRP) conjugated probe is added and binds to Certolizumab pegol captured by the reactant on the surface of the wells. Following incubation wells are washed and the bound enzymatic activit
Size
96 assays
Concentration
n/a
Applications
Detection Range: 12 - 1000 ng/ml,Cross Reactivity: Except for Certolizumab pegol, there is no cross reaction with other therapeutic antibodies and native serum immunoglobins,Sensitivity: 12 ng/ml,Assay Precision: Intra-Assay: CV < 15%; Inter-Assay: CV < 15% (CV (%) = SD/mean X 100),Recovery rate: 85 - 115% with normal human serum samples with known concentrations,This ELISA kit is used for in vitro quantitative determination of Certolizumab pegol